Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients

Oncologist. 2021 Aug;26(8):e1483. doi: 10.1002/onco.13809. Epub 2021 May 12.

Authors

Sara M Tolaney, David R Ziehr, Hao Guo, Mei R Ng, William T Barry, Michaela J Higgins, Steven J Isakoff, Jane E Brock, Elena V Ivanova, Cloud P Paweletz, Michelle K Demeo, Nikhil H Ramaiya, Beth A Overmoyer, Rakesh K Jain, Eric P Winer, Dan G Duda

No abstract available

Publication types

Published Erratum